erythromycin has been researched along with lipid a in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhando, T; Borrillo, L; Brown, ED; Coombes, BK; Farha, MA; Fragis, M; Jardine, E; Johnson, JW; Klobucar, K; MacKinnon, MR; Magolan, J; Nkonge, B; Tsai, CN | 1 |
1 other study(ies) available for erythromycin and lipid a
| Article | Year |
|---|---|
Genetic and Chemical Screening Reveals Targets and Compounds to Potentiate Gram-Positive Antibiotics against Gram-Negative Bacteria.
Topics: Anti-Bacterial Agents; Erythromycin; Gram-Negative Bacteria; Linezolid; Lipid A; Novobiocin; Oxazolidinones; Rifampin; Vancomycin | 2022 |